- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.16 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 01: 3,3',3''-({(4R)-1-[(2R,3R,4S,5R)-5-({[(S)-{[(S)-{[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}methyl)-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1,4-dihydropyridin-4-yl}-lambda~5~-phosphanetriyl)tripropanoic acid
01.1: 27 residues within 4Å:- Chain A: A.90, T.91, I.92, T.93, R.98, S.110, N.112, R.116, R.125, D.291, D.295, A.323, A.324, H.325, G.326, T.327, V.328, T.329, R.330, H.331, S.342, T.343, N.344, D.391
- Chain B: D.268
- Ligands: GOL.4, CA.6
25 PLIP interactions:25 interactions with chain A- Hydrogen bonds: A:T.91, A:T.93, A:T.93, A:R.98, A:R.98, A:S.110, A:N.112, A:A.324, A:G.326, A:T.327, A:V.328, A:T.329, A:N.344, A:N.344
- Water bridges: A:G.113, A:R.116, A:R.116, A:R.125, A:R.125, A:R.125, A:E.322
- Salt bridges: A:R.116, A:R.125, A:R.330, A:H.331
01.7: 29 residues within 4Å:- Chain A: I.231, D.268
- Chain B: K.88, A.90, T.91, I.92, T.93, R.98, S.110, N.112, R.116, R.125, D.291, D.295, A.323, A.324, H.325, G.326, T.327, V.328, T.329, R.330, H.331, S.342, T.343, N.344, D.391
- Ligands: GOL.11, CA.13
31 PLIP interactions:28 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:K.88, B:T.91, B:T.91, B:T.93, B:T.93, B:T.93, B:R.98, B:R.98, B:S.110, B:N.112, B:A.324, B:G.326, B:T.327, B:V.328, B:T.329, B:N.344, B:N.344, A:D.268
- Water bridges: B:N.112, B:R.116, B:R.116, B:R.125, B:R.125, B:T.329, B:R.330, A:K.228, A:T.230
- Salt bridges: B:R.116, B:R.125, B:R.330, B:H.331
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
CA.6: 5 residues within 4Å:- Chain A: D.291, D.295
- Chain B: D.268
- Ligands: 01.1, GOL.4
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain B- Metal complexes: A:D.291, A:D.291, A:D.295, B:D.268
CA.13: 5 residues within 4Å:- Chain A: D.268
- Chain B: D.291, D.295
- Ligands: 01.7, GOL.11
4 PLIP interactions:3 interactions with chain B, 1 interactions with chain A- Metal complexes: B:D.291, B:D.291, B:D.295, A:D.268
- 1 x SCN: THIOCYANATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mealka, M. et al., Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanisms. Nat Commun (2024)
- Release Date
- 2024-04-24
- Peptides
- Isocitrate dehydrogenase [NADP] cytoplasmic: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.16 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 01: 3,3',3''-({(4R)-1-[(2R,3R,4S,5R)-5-({[(S)-{[(S)-{[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}methyl)-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1,4-dihydropyridin-4-yl}-lambda~5~-phosphanetriyl)tripropanoic acid
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
- 1 x SCN: THIOCYANATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mealka, M. et al., Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanisms. Nat Commun (2024)
- Release Date
- 2024-04-24
- Peptides
- Isocitrate dehydrogenase [NADP] cytoplasmic: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B